The International Maritime Organization (IMO) has introduced its groundbreaking Net-Zero Framework, making shipping the first global industry with binding emissions reductions. Key news includes the 2027 enforcement of a mandatory greenhouse gas pricing mechanism and a goal-based marine fuel standard. The framework targets a 40% reduction in carbon intensity by 2030 and mandates lifecycle “well-to-wake” […]
Origin Materials has successfully commercialized its 100% PET caps, with the first products hitting stores in August 2025 and a major initial order from Berlin Packaging secured in October. The company commenced production on its first CapFormer line in early 2025 and plans to scale to 8–10 lines by 2026. Origin projects 20–30 million in […]
Opal Fuels reported a 30% year-over-year increase in third-quarter RNG production, though Adjusted EBITDA fell to $19.5 million due to lower RIN prices and expired pathways. The company currently operates 12 RNG facilities with four more under construction, representing significant capacity growth. Opal reaffirmed its full-year 2025 Adjusted EBITDA guidance of 90–110 million and highlighted […]
Following its January 2024 creation, Novonesis unveiled its “Strategy 2030,” targeting 6–9% organic sales CAGR and an adjusted EBITDA margin of approximately 39% by the end of the decade. The company is expanding beyond its core 20 billion EUR playing field into a broader 60 billion EUR biosolutions market. Key growth drivers include investments in […]
Green Plains reported strong 3Q 2025 progress, highlighting the completion of its Obion, Tennessee plant sale to repay $130.7 million in debt. The company’s decarbonization strategy is advancing with carbon capture fully operational at its York, Nebraska facility, while systems at Central City and Wood River are ramping up. Management executed a 45Z tax credit […]
Dyadic is pivoting from R&D to revenue generation with recombinant protein product launches slated for 2025–2027. Highlights include successful Phase 1 results for their DYAI-100 COVID-19 vaccine candidate and significant funding wins—a $4.5 million CEPI grant and $3 million from the Gates Foundation—to accelerate affordable vaccine and mAb production for global health. The company is […]
Ginkgo Bioworks continues to reduce cash burn while expanding its “Lab-as-a-Service” automation offerings and frontier autonomous lab in Boston. Key commercial highlights include a $22.1 million BARDA award for onshoring medical countermeasures and an extended strategic partnership with Bayer to develop next-generation biologicals like nitrogen-fixing microbes. Despite ongoing restructuring, Ginkgo maintains a strong balance sheet […]
dsm-firmenich is advancing its strategic portfolio transformation by separating its Animal Nutrition & Health business, with an exit expected in 2025. The company is focusing on high-growth segments in Nutrition, Health, and Beauty, showcasing innovations like plant-based tuna alternatives and microbiome-targeted gut health solutions. Financial highlights include a planned €1 billion share buyback, the completion […]
Corteva is on track to separate into two independent market leaders by late 2026, with the “New Corteva SpinCo” focusing on advanced genetics, gene editing, and biofuels. Commercially, the company raised its full-year 2025 operating EBITDA guidance to 3.80–3.90 billion, driven by strong seed volumes in North America and new crop protection product gains. The […]
Corbion has launched its “BRIGHT 2030” strategy, pivoting toward fermentation-based natural preservation and nutrition while initiating a strategic review of its PLA portfolio. The company highlights its leadership in algae-derived omega-3 oils, securing long-term aquaculture contracts and expanding into nutraceuticals. Commercial highlights include double-digit growth in biomedical polymers driven by the UZEDY® partnership with MedinCell. […]
